Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05793957 · ClinicalTrials.gov registry record · NA
Use of Virtual Reality Goggles During Chemotherapy Infusion to Reduce Anxiety-Related Symptoms
A NA study, sponsored by OHSU Knight Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT05793957 is a NA study that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 50 participants.
The verdict
NCT05793957, a NA study, has completed, sponsored by OHSU Knight Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This clinical trial evaluates the use of virtual reality (VR) goggles during chemotherapy infusion to reduce anxiety-related symptoms in patients with head and neck, thoracic, hematologic, and breast cancers. Virtual reality headsets provide the ability for users to explore a simulated, three-dimensional environment with which users can interact. In virtual reality users can play interactive games, enjoy relaxing experiences, and watch immersive videos. The use of VR goggles may help with anxiety management during chemotherapy infusion.
Interventions
- OTHER Questionnaire Administration
- BEHAVIORAL Telephone-Based Intervention
- OTHER Virtual Technology Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-04-20 |
| Est. Completion | 2023-09-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05793957
The ClinicalTrials.gov registry entry for NCT05793957 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT05793957 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05793957 about?
NCT05793957 is a clinical study titled "Use of Virtual Reality Goggles During Chemotherapy Infusion to Reduce Anxiety-Related Symptoms". This clinical trial evaluates the use of virtual reality (VR) goggles during chemotherapy infusion to reduce anxiety-related symptoms in patients with head and neck, thoracic, hematologic, and breast cancers. Virtual reality headsets provide the ability for users to explore a simulated, three-dimens...
What is the current status of trial NCT05793957?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2023-04-20. Estimated completion is 2023-09-28.
What interventions are being tested in trial NCT05793957?
The interventions under investigation include: Questionnaire Administration (OTHER), Telephone-Based Intervention (BEHAVIORAL), Virtual Technology Intervention (OTHER).
Who is sponsoring clinical trial NCT05793957?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.